A Controlled Study of Peripheral Neuropathy After Bariatric Surgery
Neurol 63:1462-1470, Thaisetthawatkul,P.,et al, 2004

The MATCH Study Results in the Context of Secondary Stroke Prevention
Stroke 35:2609, Fisher,M. &Davalos,A., 2004

Should the MATCH Results be Extrapolated to All Stroke Patients and Affect Ongoing Trials Evaluating Clopidogrel Plus Aspiring?
Stroke 35:2606-2608, Amarenco,P. &Donna,G. A., 2004

Thoughts Evoked by MATCH and Other Trials
Stroke 35:2604-2605, Caplan,L.R., 2004

Natural History of Nonketotic Hyperglycinemia in 65 Patients
Neurol 63:1847-1853, Hoover-Fong,J.E.,et al, 2004

Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004

Routine Use of Gradient-Echo MRI to Screen for Cerebral Amyloid Angiopathy in Elderly Patients
AJR 182:1547-1550, Walker,D.A., et al, 2004

Copper Deficiency Myelopathy Produces a Clinical Picture Like Subacute Combined Degeneration
Neurol 63:33-39, Kumar,N.,et al, 2004

Guillain-Barre Syndrome Seen in Users of Isotretinoin
BMJ 328:1537, Pritchard,J.,et al, 2004

Fish Consumption and Incidence of Stroke
Stroke 35:1538-1542, He,K.,et al, 2004

Antiplatelet Drug Discontinuation is a Risk Factor for Ischemic Stroke
Neurol 62:1187-1189, Sibon,I. &Orgogozo,J-M., 2004

Cerebral Palsy
Lancet 363:1619-1631, Koman,L.A.,et al, 2004

Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004

Multiple Cerebral Aneurysms in Factor VII Deficiency
AJNR 25:784-786, Schilling,A.M.,et al, 2004

Recurrent Acroparaesthesia During Febrile Infections
Lancet 363:1698, Bodamer,O.A.,et al, 2004

Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004

Penetrance of the Fragile X-Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
JAMA 291:460-469, Jacquemont,S.,et al, 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Clopidogrel-Associated TTP, An Update of Pharmacovigilance Efforts
Stroke 35:533-538, Zakarija,A.,et al, 2004

Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004

Benefit of Clopidogrel Over Aspirin is Amplified in Patients with a History of Ischemic Events
Stroke 35:528-532, Ringleb,P.A.,et al, 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Late-Onset Cerebellar Ataxia with Hypogonadism and Muscle Coenzyme Q10 Deficiency
Neurol 62:818-820, Gironi,M.,et al, 2004

Variants and Mimics of Guillain Barre Syndrome
The Neurologist 10:61-74, Levin,K.H., 2004

Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004

Copper Deficiency Myelopathy
Arch Neurol 61:762-766, Kumar,N.,et al, 2004

Wernicke Encephalopathy
Arch Neurol 61:775-776, Morcos,Z.,et al, 2004

Neurologic Manifestations of Kanzaki Disease
Neurol 62:1604-1606, Umehara,F.,et al, 2004

Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004

Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004

Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004

Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003

Myelopathy Due to Copper Deficiency Following Gastrointestinal Surgery
Arch Neurol 60:1782-1785, Kumar,N.,et al, 2003

Clinicopath Conf., Colchicine Myoneuropathy
NEJM 349:1656-1663, Case 33-2003, 2003

Wernicke's Encephalopathy in AIDS: A Preventable Cause of Fatal Neurological Deficit
Int J STD AIDS 14:712-713, Alcaide,M.L.,et al, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Intellectual Impairment in children with Blood Lead Concentrations Below 10 ug per Deciliter
NEJM 348:1517-1526,1515, Canfield,R.L.,et al, 2003

Cerebellar Ataxia and Coenzyme Q10 Deficiency
Neurol 60:1206-1208, Lamperti,C.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003

The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Proton MR Spectroscopy in Wernicke Encephalopathy
AJNR 24:952-955, Rugilo,C.A.,et al, 2003

Neurologic Manifestations of Vitamin B12 Deficiency
NEJM 348:2208, Scherer,K., 2003

Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003

Cognitive Presentation of Multiple Sclerosis: Evidence for a Cortical Variant
JNNP 74:872-877, Zarei,M.,et al, 2003

Neurotoxicity Following Addition of Intravenous Valproate to Lamotrigine Therapy
Neurol 60:1991-1992, Burneo,J.G.,et al, 2003